We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

44 hedge funds and large institutions have $4.94M invested in vTv Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 7

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

13% more funds holding

Funds holding: 39 → 44 (+5)

0.09% less ownership

Funds ownership: 0.21% → 0.12% (-0.09%)

31% less capital invested

Capital invested by funds: $7.14M → $4.94M (-$2.2M)

Holders
44
Holders Change
+5
Holders Change %
+12.82%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
14
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$361K
2
Renaissance Technologies
Renaissance Technologies
New York
+$145K
3
BlackRock
BlackRock
New York
+$128K
4
VF
Virtu Financial
New York
+$72.2K
5
EGM
Engineers Gate Manager
New York
+$66.6K

Top Sellers

Rank Fund Capital Flow
1
FM
Frazier Management
Washington
-$1.88M
2
Two Sigma Investments
Two Sigma Investments
New York
-$889K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$829K
4
Wells Fargo
Wells Fargo
California
-$131K
5
GCP
GSA Capital Partners
United Kingdom
-$68K
Name Holding Trade Value Shares
Change 		Change in
Stake
XM
26
XTX Markets
New York
$27K +$28.1K +367 New
CS
27
Credit Suisse
Switzerland
$24K +$25.3K +330 New
Morgan Stanley
28
Morgan Stanley
New York
$19K +$16.3K +213 +533%
UBS Group
29
UBS Group
Switzerland
$18K +$1.69K +22 +10%
Deutsche Bank
30
Deutsche Bank
Germany
$13K +$4.06K +53 +43%
TRCT
31
Tower Research Capital (TRC)
New York
$10K -$7.82K -102 -43%
Barclays
32
Barclays
United Kingdom
$7K -$2.07K -27 -23%
Bank of America
33
Bank of America
North Carolina
$5K +$2.15K +28 +85%
Legal & General Group
34
Legal & General Group
United Kingdom
$4K – – –
Osaic Holdings
35
Osaic Holdings
Arizona
$4K – – –
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$4K +$2.61K +34 +283%
PA
37
Parallel Advisors
California
$3K – – –
Citigroup
38
Citigroup
New York
$3K +$2.53K +33 +254%
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$2.47K -$1.84K -24 -42%
AIP
40
Ameritas Investment Partners
Nebraska
$2K – – –
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$2K +$690 +9 +60%
PAM
42
Panagora Asset Management
Massachusetts
$1K – – –
AIG
43
American International Group
New York
$12 +$307 +4 +3%
FM
44
Frazier Management
Washington
– -$1.88M -26,550 Closed
Two Sigma Investments
45
Two Sigma Investments
New York
– -$889K -12,562 Closed
GCP
46
GSA Capital Partners
United Kingdom
– -$68K -958 Closed
Millennium Management
47
Millennium Management
New York
– -$40 -566 Closed
WS
48
Wedbush Securities
California
– -$39K -550 Closed
Jane Street
49
Jane Street
New York
– -$28K -395 Closed
Citadel Advisors
50
Citadel Advisors
Florida
– -$26K -363 Closed
1
2
3

VTVT Hedge Fund Activity: Q4 2020 in Review

44 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q4 2020, worth a combined $4.94M — down 31% from $7.14M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new VTVT positions and 9 closed out — a net gain of 5 holders — while 14 added to existing stakes and 7 trimmed.

The largest buyer was Ensign Peak Advisors, opening a new position worth an estimated $361K. The largest seller was Frazier Management, exiting entirely with an estimated $1.88M sold.

  • 44 institutional investors held vTv Therapeutics (VTVT) as of Q4 2020, up from 39 in Q3 2020.
  • Funds reported $4.94M of vTv Therapeutics stock for Q4 2020, down 31% quarter-over-quarter.
  • 14 funds opened new vTv Therapeutics positions in Q4 2020 and 9 closed out, a net change of +5 holders.
  • The largest vTv Therapeutics buyer in Q4 2020 was Ensign Peak Advisors, an estimated $361K added.
  • The largest vTv Therapeutics seller in Q4 2020 was Frazier Management, an estimated $1.88M sold.

Based on aggregated 13F filings for Q4 2020.